[HTML][HTML] Prostate cancer review: genetics, diagnosis, treatment options, and alternative approaches
M Sekhoacha, K Riet, P Motloung, L Gumenku… - Molecules, 2022 - mdpi.com
Simple Summary Prostate cancer affects men of all racial and ethnic groups and leads to
higher rates of mortality in those belonging to a lower socioeconomic status due to late …
higher rates of mortality in those belonging to a lower socioeconomic status due to late …
[HTML][HTML] Triclosan: A small molecule with controversial roles
MS Sinicropi, D Iacopetta, J Ceramella, A Catalano… - Antibiotics, 2022 - mdpi.com
Triclosan (TCS), a broad-spectrum antimicrobial agent, has been widely used in personal
care products, medical products, plastic cutting boards, and food storage containers …
care products, medical products, plastic cutting boards, and food storage containers …
Computational drug discovery for castration-resistant prostate cancers through in vitro drug response modeling
Prostate cancer (PC) is the most frequently diagnosed malignancy and a leading cause of
cancer deaths in US men. Many PC cases metastasize and develop resistance to systemic …
cancer deaths in US men. Many PC cases metastasize and develop resistance to systemic …
[HTML][HTML] Epithelial-to-mesenchymal transition-related markers in prostate cancer: From bench to bedside
S Gogola, M Rejzer, HF Bahmad, W Abou-Kheir… - Cancers, 2023 - mdpi.com
Simple Summary Prostate cancer (PCa) is the second most frequent type of cancer in men
worldwide. Treatment options for early-stage PCa include external beam radiation therapy …
worldwide. Treatment options for early-stage PCa include external beam radiation therapy …
[HTML][HTML] Drug repurposing in non-small cell lung carcinoma: old solutions for new problems
Lung cancer is the second most common cancer and the leading cause of cancer-related
deaths in 2022. The majority (80%) of lung cancer cases belong to the non-small cell lung …
deaths in 2022. The majority (80%) of lung cancer cases belong to the non-small cell lung …
[HTML][HTML] Pharmacological efficacy of repurposing drugs in the treatment of prostate cancer
T Lourenço, N Vale - International Journal of Molecular Sciences, 2023 - mdpi.com
Worldwide, prostate cancer (PC) is the second most frequent cancer among men and the
fifth leading cause of death; moreover, standard treatments for PC have several issues, such …
fifth leading cause of death; moreover, standard treatments for PC have several issues, such …
[HTML][HTML] Drug repurposing to enhance antitumor response to PD-1/PD-L1 immune checkpoint inhibitors
X Thuru, R Magnez, H El-Bouazzati, G Vergoten… - Cancers, 2022 - mdpi.com
Simple Summary Novel pharmacological approaches are needed to improve treatments of
advanced cancers, despite the considerable benefit of immunotherapy. New drugs are …
advanced cancers, despite the considerable benefit of immunotherapy. New drugs are …
[HTML][HTML] Current trends and future prospects of drug repositioning in gastrointestinal oncology
Gastrointestinal (GI) cancers comprise a significant number of cancer cases worldwide and
contribute to a high percentage of cancer-related deaths. To improve survival rates of GI …
contribute to a high percentage of cancer-related deaths. To improve survival rates of GI …
[HTML][HTML] Identification of Promising Drug Candidates against Prostate Cancer through Computationally-Driven Drug Repurposing
L Bernal, L Pinzi, G Rastelli - International Journal of Molecular Sciences, 2023 - mdpi.com
Prostate cancer (PC) is one of the most common types of cancer in males. Although early
stages of PC are generally associated with favorable outcomes, advanced phases of the …
stages of PC are generally associated with favorable outcomes, advanced phases of the …
[HTML][HTML] Target repositioning using multi-layer networks and machine learning: the case of prostate cancer.
The discovery of novel therapeutic targets, defined as proteins which drugs can interact with
to induce therapeutic benefits, typically represent the first and most important step of drug …
to induce therapeutic benefits, typically represent the first and most important step of drug …